Trends in clinical success rates

descriptionPublicationkeyboard_double_arrow_right Article 20 May 2016 English Publisher:Springer Science and Business Media LLCJournal:Nature Reviews Drug Discovery, volume 15, pages 379-380 (issn: 1474-1776, eissn: 1474-1784,

Copyright policy )

Authors: Katarzyna, Smietana; Marcin, Siatkowski; Martin, Møller;

doi: 10.1038/nrd.2016.85

pmid: 27199245

Trends in clinical success rates

- Summary
- Subjects
- Metrics

Abstract

This analysis of the industry's clinical-stage portfolio in the past two decades reveals several trends, including a recent improvement in success rates in late-stage trials, an increase in overall portfolio size and higher success rates for biologics and partnered projects.

Related Organizations

McKinsey & Company
United States

Keywords

Biological Products, Clinical Trials as Topic, Research Design, Humans

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	233
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 0.1%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 1%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 1%